2023
Clinical predictive value of renalase in post-ERCP pancreatitis
Muniraj T, Desir G, Gorelick F, Guo X, Ciarleglio M, Deng Y, Jamidar P, Farrell J, Aslanian H, Laine L. Clinical predictive value of renalase in post-ERCP pancreatitis. Gastrointestinal Endoscopy 2023, 99: 822-825.e1. PMID: 38103747, DOI: 10.1016/j.gie.2023.12.020.Peer-Reviewed Original ResearchPost-ERCP pancreatitisRenalase levelsPlasma renalase levelsProspective cohort studyPotential clinical roleAcute experimental pancreatitisLongitudinal regression modelsPEP patientsPlasma renalaseCohort studyTertiary hospitalClinical roleExperimental pancreatitisRenalaseAbstractTextERCPPancreatitisFurther studiesAIMSRegression models
2021
S1030 Prevalence and Predictors of Musculoskeletal Disorders Amongst Nurses and Technicians Assisting in ERCP
Mbachi C, Jamidar P, Muniraj T, Farrell J, , Campbell E, Aslanian H. S1030 Prevalence and Predictors of Musculoskeletal Disorders Amongst Nurses and Technicians Assisting in ERCP. The American Journal Of Gastroenterology 2021, 116: s489-s489. DOI: 10.14309/01.ajg.0000777652.16974.b4.Peer-Reviewed Original Research
2015
Can a Computerized Simulator Assess Skill Level and Improvement in Performance of ERCP?
Sahakian AB, Laine L, Jamidar PA, Siddiqui UD, Duffy A, Ciarleglio MM, Deng Y, Nagar A, Aslanian HR. Can a Computerized Simulator Assess Skill Level and Improvement in Performance of ERCP? Digestive Diseases And Sciences 2015, 61: 722-730. PMID: 26572779, DOI: 10.1007/s10620-015-3939-7.Peer-Reviewed Original ResearchConceptsTotal procedure timeProcedure timePrimary outcomeAcademic tertiary referral centerShorter total procedure timeTertiary referral centerPerformance of ERCPReferral centerCohort studyRetrograde cholangiographyERCP proceduresTrainee experienceGastroenterology fellowsSurgical skills centerFlexible endoscopyERCP trainingLittle dataGastroenterology facultyERCPSignificant differencesConsiderable riskSession 2Session 1Baseline sessionsOutcomes
2005
Oral allopurinol does not prevent the frequency or the severity of post-ERCP pancreatitis
Mosler P, Sherman S, Marks J, Watkins JL, Geenen JE, Jamidar P, Fogel EL, Lazzell-Pannell L, Temkit M, Tarnasky P, Block KP, Frakes JT, Aziz AA, Malik P, Nickl N, Slivka A, Goff J, Lehman GA. Oral allopurinol does not prevent the frequency or the severity of post-ERCP pancreatitis. Gastrointestinal Endoscopy 2005, 62: 245-250. PMID: 16046988, DOI: 10.1016/s0016-5107(05)01572-5.Peer-Reviewed Original ResearchConceptsPost-ERCP pancreatitisOral allopurinolAllopurinol groupControl groupOxygen-derived free radical productionPlacebo 4 hoursProcedure risk factorsCommon major complicationSeverity of pancreatitisFree radical productionProphylactic allopurinolPatient demographicsMajor complicationsOverall incidencePostprocedure pancreatitisPharmacologic agentsRisk factorsPancreatitisPatientsStandardized criteriaAllopurinolERCPSeveritySignificant differencesIncidence
1994
Survey of informed consent for endoscopic retrograde cholangiopancreatography
Newton J, Hawes R, Jamidar P, Harig J, Lehman G. Survey of informed consent for endoscopic retrograde cholangiopancreatography. Digestive Diseases And Sciences 1994, 39: 1714-1718. PMID: 8050323, DOI: 10.1007/bf02087782.Peer-Reviewed Original ResearchConceptsTherapeutic ERCPProlonged hospital stayEndoscopic retrograde cholangiopancreatographyHealth care team membersGastrointestinal endoscopic proceduresPrivate practice physiciansHospital stayRetrograde cholangiopancreatographyInformed consent processPractice physiciansEndoscopic proceduresAdequate informationPatientsPhysiciansConsent processVariation of opinionERCPConsentPotential needCurrent opinionPotential riskCholangiopancreatographyPancreatitisStaySurgery